Previous 10 | Next 10 |
Along with taking a huge toll in terms of human suffering and death, and upending everyday life, the novel coronavirus pandemic has caused extreme turbulence in the stock market. Investors are naturally concerned about the magnitude of the economic fallout from the crisis. Last week, all t...
While high-momentum stocks have completely dominated cheaper value stocks over the past decade since the 2008 global financial crisis, recent events have turned the tables in a big way. There's no better example than the success of recent stock picks by Berkshire Hathaway (NYSE: BRK.A) ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Big gains were seen across every asset class overnight as policymakers pulled out all the stops and adopted a "whatever it takes" app...
Mylan (NASDAQ: MYL) has restarted production of its hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility as a potential treatment for COVID-19 , the disease caused by the new coronavirus. The company plans to have product available by mid-April and thinks it can ra...
Mylan N.V. ( MYL +6% ) has restarted production of hydroxychloroquine sulfate tablets at its West Virginia facility in order to meet COVID-19-related demand, although it is not formerly approved for this use (currently authorized to treat malaria, lupus erythematosus and rheumatoid arthr...
HERTFORDSHIRE , England and PITTSBURGH, March 19, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its continued commitment to do its part in support of public health needs amidst the evolving COVID-19 pandemic. The company continues to focus its efforts...
March 16, 2020 Palm Beach, FL – March 16, 2020 – The U.S. and other countries worldwide are sharing information and mobilizing to collectively corral the coronavirus pandemic with all due speed. As a result, a new and private/public collaboration has been formed and it i...
Choosing between biotech giants Biogen (NASDAQ: BIIB) and Amgen (NASDAQ: AMGN) is not an easy task. Both companies have attractive pipelines and solid suites of products on the market. Though Amgen's revenue declined in 2019 while Biogen's rose, Amgen offered a better revenue outloo...
Drug stocks soared on Friday with the overall stock market rebounding from Thursday's historic sell-off. Several also spiked near the end of the day today as President Trump held a news conference where he declared a national emergency that he said would "open up access" to up to $50 billion to ...
Pharma giants Pfizer (NYSE: PFE) and GlaxoSmithKline (NYSE: GSK) share similar visions for the future. Both aim to transform into smaller, nimbler biopharmaceutical outfits focused on high-value R&D. Last year, investors witnessed the strategy begin to take shape at both businesses. ...
News, Short Squeeze, Breakout and More Instantly...
Mylan N.V. Company Name:
MYL Stock Symbol:
NASDAQ Market:
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...